Nu Skin and its research partner LifeGen Technologies presented their latest research findings on how dietary interventions affect aging and longevity at the First International Congress on Controversies in Longevity, Health and Aging (CoLONGY) in Barcelona, Spain. Nu Skin and LifeGen presented research on the identification of genetic biomarkers of aging, and how gene expression can be modulated by dietary interventions.

“Nu Skin’s ageLOC approach to anti-aging looks at the level of genetic expression of aging and is supported by our partnerships with some of the best minds in anti-aging science, such as our colleagues at LifeGen Technologies,” said Joe Chang, Nu Skin chief scientific officer and executive vice president of product development. “Identifying functional Youth Gene Clusters and understanding how ingredients can target and reset those genes to a more youthful profile helps us develop next-generation skin care and nutritional products.”

The joint research identified robust, tissue-specific panels of transcriptional biomarkers that are relevant to aging. Studies using whole-genome profiles of gene expression have identified thousands of genes that change activity patterns with age. Nu Skin is currently using these biomarkers in a pre-clinical study of dietary compounds to determine their ability to impact aging at the genetic expression level.

This fall Nu Skin will introduce ageLOC Vitality, a new dietary supplement to address a key concern of aging – loss of vitality. The new product builds on the research presented at the CoLONGY conference and the company has submitted a patent application for the unique blend of ingredients that have been identified with this technology to support youthful genetic expression of vitality.